These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6183686)

  • 1. The present status of clinical studies with interferons in cancer in Britain.
    Priestman TJ
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):119-24. PubMed ID: 6183686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma: therapeutic options with recombinant interferons.
    Kirkwood JM; Ernstoff M
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):7-12. PubMed ID: 2417333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.
    Budd GT; Murthy S; Finke J; Sergi J; Gibson V; Medendorp S; Barna B; Boyett J; Bukowski RM
    J Clin Oncol; 1992 May; 10(5):804-9. PubMed ID: 1569452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferons in the treatment of advanced breast cancer.
    Repetto L; Venturino A; Simoni C; Rosso M; Melioli G; Rosso R
    J Biol Regul Homeost Agents; 1993; 7(4):109-14. PubMed ID: 7517612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
    Wadler S; Schwartz EL
    Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant interferon treatment of melanoma].
    Török L
    Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
    Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
    J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of interferon in the treatment of renal cancer in adults].
    Bergerat JP; Dufour P
    Rev Prat; 1992 May; 42(10):1246-52. PubMed ID: 1376937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.
    Figlin RA; Abi-Aad AS; Belldegrun A; deKernion JB
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):102-7. PubMed ID: 1719641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
    Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma.
    Kirkwood JM; Ernstoff M
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):48-56. PubMed ID: 3532336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
    Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
    J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I pharmacotoxicology study of human fibroblast interferon in human cancers.
    McPherson TA; Tan YH
    J Natl Cancer Inst; 1980 Jul; 65(1):75-9. PubMed ID: 6156261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma: treatment with interferon.
    Grosh WW
    Compr Ther; 1987 Jun; 13(6):34-9. PubMed ID: 2438082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
    Alatrash G; Hutson TE; Molto L; Richmond A; Nemec C; Mekhail T; Elson P; Tannenbaum C; Olencki T; Finke J; Bukowski RM
    J Clin Oncol; 2004 Jul; 22(14):2891-900. PubMed ID: 15254058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; De Vassal F; Horoszewicz JS
    Anticancer Res; 1982; 2(1-2):63-6. PubMed ID: 6180675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of interferons in the therapy of melanoma.
    Kirkwood JM
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):83-90. PubMed ID: 1948134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.